• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [121 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2007 Penn Medicine Center for Evidence-based Practice (CEP) Fondaparinux for treatment of venous thromboembolism
2007 Penn Medicine Center for Evidence-based Practice (CEP) Venous thromboembolism prophylaxis for hip fracture patients
2007 The Netherlands Organisation for Health Research and Development (ZonMw) [Safety and cost-effectiveness of a diagnostic decision rule for suspected deep venous thrombosis in thrombosis in general practice]
2007 NIHR Horizon Scanning Centre (NIHR HSC) Rivaroxaban (Bay 59-7939) for the prevention of venous thromboembolism (VTE) after major orthopaedic surgery: horizon scanning technology briefing
2005 Danish Institute for Health Services Research (DSI) Thrombo-Base. A technology assessment of a decision support system and a clinical database for anticoagulant treatment
2005 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Device for treatment of ischemic stroke
2005 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Platelet aggregation inhibitors in primary and secondary prevention of ischemic stroke
2005 NIHR Health Technology Assessment programme Developing evidence-based guidelines for the prevention of venous thromboembolism in surgical patients- systematic review
2004 NIHR Horizon Scanning Centre (NIHR HSC) Idraparinux sodium for the treatment and secondary prevention of recurrent venous thromboembolism (VTE) - horizon scanning review
2004 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Ximelagatran for prevention and treatment of venous thromboembolism
2004 The Swedish Council on Health Technology Assessment (SBU) Fondaparinux (Arixtra) - prevention of venous thromboembolism after orthopedic surgery - early assessment briefs (Alert)
2003 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Ximelagatran for the prophylaxis of various complications due to thrombosis
2002 Agency for Healthcare Research and Quality (AHRQ) Hormone replacement therapy and risk of venous thromboembolism
2002 Adelaide Health Technology Assessment (AHTA) Antenatal screening for heritable thrombophilia
2002 West Midlands Health Technology Assessment Collaboration (WMHTAC) Air travel as a risk factor for venous thromboembolism (VTE) and the effectiveness of preventive measures
2002 The Swedish Council on Health Technology Assessment (SBU) Prevention, diagnosis, and treatment of venous thromboembolism
2002 Basque Office for Health Technology Assessment (OSTEBA) [Low molecular weight heparins versus traditional heparins in thromboembolic diseases]
2001 NIHR Horizon Scanning Centre (NIHR HSC) Fondaparinux for venous thromboembolism - horizon scanning review
2001 Centre for Clinical Effectiveness (CCE) In patients with cerebral metastases is anticoagulation therapy for thromboembolic disease associated with an increased risk of cerebral haemorrhage?
2000 Agency for Healthcare Research and Quality (AHRQ) Prevention of venous thromboembolism after injury
1999 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Postoperative use of antiembolism stockings: patient's use, practice and information]